Covaxin effective on Delta variant of Corona

| Updated: July 3, 2021 8:19 pm

Covaxin works on Delta variant, 77.8% effective against symptomatic covid cases.
Additional clinical trials to establish safety and efficacy in children of 2-18 years of age are on. A clinical trial to determine the safety and immunogenicity of a booster dose is also in the process

Your email address will not be published. Required fields are marked *